Guideline | Management of pheochromocytoma and paraganglioma in patients harboring germline SDHD pathogenic variants
24 Apr, 2023 | 13:32h | UTCClinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
Clinical consensus guideline on the management of #phaeochromocytoma and #paraganglioma in patients harbouring germline #SDHD pathogenic variants https://t.co/PJSiZnUXga #FREE to read with registration (also FREE) pic.twitter.com/WJA5ZGsK8d
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) April 16, 2023